|
C1GALT1C1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.140600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.727400E-01 |
| Normal-vs-Stage2 |
4.049800E-01 |
| Normal-vs-Stage3 |
3.643200E-01 |
| Normal-vs-Stage4 |
5.132000E-01 |
| Stage1-vs-Stage2 |
6.468300E-02 |
| Stage1-vs-Stage3 |
1.964310E-02 |
| Stage1-vs-Stage4 |
8.904300E-02 |
| Stage2-vs-Stage3 |
8.833000E-01 |
| Stage2-vs-Stage4 |
8.997200E-01 |
| Stage3-vs-Stage4 |
9.908800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.883400E-01 |
| Normal-vs-AfricanAmerican |
9.198400E-01 |
| Normal-vs-Asian |
1.055790E-01 |
| Caucasian-vs-AfricanAmerican |
7.685200E-01 |
| Caucasian-vs-Asian |
1.267150E-01 |
| AfricanAmerican-vs-Asian |
2.095000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.639400E-01 |
| Normal-vs-Female |
5.337800E-01 |
| Male-vs-Female |
3.161000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.444840E-01 |
| Normal-vs-Age(41-60Yrs) |
6.340400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.621700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.324200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.561200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.428600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.807400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.240600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.341400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.669000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.048600E-01 |
| Classical-VS-Follicular |
6.11369999958811E-07 |
| Classical-VS-Other |
6.962800E-01 |
| Classical-VS-Normal |
6.322500E-02 |
| Tall-VS-Follicular |
1.571430E-01 |
| Tall-VS-Other |
6.807400E-01 |
| Tall-VS-Normal |
6.201200E-01 |
| Follicular-VS-Other |
2.630400E-01 |
| Follicular-VS-Normal |
1.138360E-02 |
| Other-VS-Normal |
8.869600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.486800E-01 |
| Normal-vs-N1 |
3.176800E-01 |
| N0-vs-N1 |
4.316400E-01 |
|
|
